2011004 Informal Interpretation
Date
Rule
7A(c)(1)
We disagree. The assets you describe are not exempt under 7A(c)(1).
File
Original Image
(283.23 KB)
Displaying 1121 - 1140 of 5013
Concurring Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Linde AG
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
171 0068
Docket Number
C-4660
Statement of Chairman Joseph J. Simons and Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding a Petition for Modification in the Matter of Linde AG
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
171 0068
Docket Number
C-4660
Dissenting Statement of Commissioner Rohit Chopra Regarding Petitions for Modifications in the Matter of Linde AG and Praxair LLC
Date
By
Rohit Chopra, Former Commissioner
Matter Number
1710068
Docket Number
C-4660
Statement of Commissioner Christine S. Wilson, Joined by Commissioner Noah Joshua Phillips, In the Matter of Methodist Le Bonheur Healthcare
Date
By
Christine S. Wilson, Former Commissioner;
Noah Joshua Phillips, Former Commissioner
Matter Number
191 0189
Docket Number
9396
FTC Sues to Block Proposed Acquisition of Two Memphis-Area Hospitals
Date
The Federal Trade Commission has filed an administrative complaint, and authorized a suit in federal court, to block the proposed $350 million acquisition by Memphis-based Methodist Le Bonheur...
2011006 Informal Interpretation
Date
Rule
801.11
Based on the facts you present, we agree that this is not income-producing property.
File
Original Image
(193.01 KB)
Federal Register Notice
Pfizer Inc. and Mylan N.V.; Analysis of Agreement Containing Consent Orders To Aid Public Comment
Date
2011001 Informal Interpretation
Date
Rule
803.5
The signatures attest to the accuracy of the filing and you need to be certain nothing has changed if you want to rely on them.
File
Original Image
(89.91 KB)
Federal Register Notice
Stryker and Wright Medical; Analysis of Consent Orders To Aid Public Comment
Date
2011003 Informal Interpretation
Date
Rule
801.13
Party A should wait and file before the closing that would confer control.
File
Original Image
(168.03 KB)
Statement of Commissioner Rohit Chopra in the Matter of Stryker and Wright Medical
Date
By
Rohit Chopra, Former Commissioner
Matter Number
201 0014
Docket Number
C-4728
FTC Requires Medical Device Companies Stryker Corp. and Wright Medical Group N.V. to Divest Assets to Preserve Competition
Date
The Federal Trade Commission will require medical device companies Stryker Corp. and Wright Medical Group N.V. to divest all assets related to Stryker’s total ankle replacements and finger joint...
Statement of Commissioner Christine S. Wilson in the Matter of Pfizer Inc./Mylan N.V.
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
191 0182
FTC Imposes Conditions on Combination of Pfizer Inc.’s Upjohn and Mylan N.V.
Date
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc...
Dissenting Statement of Commissioner Rohit Chopra Joined by Commissioner Rebecca Kelly Slaughter in the Matter of Pfizer Inc./Mylan N.V.
Date
By
Rohit Chopra, Former Commissioner
Matter Number
191 0182
2010002 Informal Interpretation
Date
Rule
801.1, 7A(a)(2)
If all of the manufacturing is performed by third parties, your client is not engaged in manufacturing for purposes of Section 7A(a)(2) and Section 801.1(j).
File
Original Image
(138.1 KB)
Displaying 1121 - 1140 of 5013